Loading…

Development and validation of a LC-MS assay for the quantification of ikh12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study

IKH12 is a novel histone deacetylase 6 selective inhibitor. A rapid and sensitive liquid chromatography tandem mass spectrometry method was developed and validated for the quantification of IKH12 in rat plasma and tissue with kendine 91 as internal standard (IS). The samples were prepared by liquid–...

Full description

Saved in:
Bibliographic Details
Published in:Biomedical chromatography 2015-08, Vol.29 (8), p.1249-1258
Main Authors: Otaegui, Dorleta, Masdeu, Carme, Aldaba, Eneko, Vara, Yosu, Zubia, Aizpea, San Sebastian, Eider, Alcalá, Maria, Villafruela, Sergio, Cossío, Fernando P., Rodriguez-Gascón, Alicia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4934-3a0a9e96a489160a6c454b33db0c00e02c1d35593451251131096cafc4a8ade53
container_end_page 1258
container_issue 8
container_start_page 1249
container_title Biomedical chromatography
container_volume 29
creator Otaegui, Dorleta
Masdeu, Carme
Aldaba, Eneko
Vara, Yosu
Zubia, Aizpea
San Sebastian, Eider
Alcalá, Maria
Villafruela, Sergio
Cossío, Fernando P.
Rodriguez-Gascón, Alicia
description IKH12 is a novel histone deacetylase 6 selective inhibitor. A rapid and sensitive liquid chromatography tandem mass spectrometry method was developed and validated for the quantification of IKH12 in rat plasma and tissue with kendine 91 as internal standard (IS). The samples were prepared by liquid–liquid extraction with tert‐butyl methyl ether. The chromatographic separation was accomplished by using a Zorbax Extend C18 4.6 × 150 mm, 5 µm column, with a mobile phase consisting of methanol and 0.1% formic acid (75:25 v/v). Multiple reaction monitoring, using electrospray ionization in positive ion mode, was employed to quantitatively detect IKH12 and IS. The monitored transitions were set at m/z 418 → 252 and 444 → 169 for IKH12 and kendine 91, respectively. The calibration curve was linear over the concentration range 2–1000 ng mL−1. The intra‐ and inter‐assay precision and accuracy of the quality controls and the limit of quantification were satisfactory in all cases (according to European Medicines Agency guidelines). Stability studies showed that plasma samples were stable in the chromatography rack for 24 h and at −80 °C for 2 months and also after three freeze–thaw cycles. This method was successfully applied to a pharmacokinetic study of IKH12 in rat. Copyright © 2015 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/bmc.3414
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1701487987</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1697211400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4934-3a0a9e96a489160a6c454b33db0c00e02c1d35593451251131096cafc4a8ade53</originalsourceid><addsrcrecordid>eNqF0ctu1DAUBmALgehQkHgC5CWblOP4kngJAQrVFIQol511xnE0ZnJr7LSdx-IN8bTTYYVYHUv-9Ns6PyHPGZwwgPzVqrMnXDDxgCwYaJ1BCewhWUCudMbLQh-RJyH8AgCt8uIxOcqlYopJsSC_37or1w5j5_pIsa_pFba-xuiHng4NRbqssvOvFEPALW2Gica1o5cz9tE33h6c36xZnnQ_pDS6u83i3CVuU-Yuz1Hf0wkjHVsMHd4-FX0Iswu3Zx_THMf2PjNppOMapw7tsPG9i97SEOd6-5Q8arAN7tl-HpNv799dVB-y5efTj9XrZWaF5iLjCKidVihKzRSgskKKFef1CiyAg9yymkuZqGS5ZIynxSmLjRVYYu0kPyYv73LHabhM34ym88G6tsXeDXMwrAAm0m7L4v9U6SJnTAD8pXYaQphcY8bJdzhtDQOz69KkLs2uy0Rf7FPnVefqA7wvL4HsDlz71m3_GWTenFf7wL33Ibqbg8dpY1TBC2l-fDo1P7-cLb_r6sxc8D8l27go</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1697211400</pqid></control><display><type>article</type><title>Development and validation of a LC-MS assay for the quantification of ikh12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Otaegui, Dorleta ; Masdeu, Carme ; Aldaba, Eneko ; Vara, Yosu ; Zubia, Aizpea ; San Sebastian, Eider ; Alcalá, Maria ; Villafruela, Sergio ; Cossío, Fernando P. ; Rodriguez-Gascón, Alicia</creator><creatorcontrib>Otaegui, Dorleta ; Masdeu, Carme ; Aldaba, Eneko ; Vara, Yosu ; Zubia, Aizpea ; San Sebastian, Eider ; Alcalá, Maria ; Villafruela, Sergio ; Cossío, Fernando P. ; Rodriguez-Gascón, Alicia</creatorcontrib><description>IKH12 is a novel histone deacetylase 6 selective inhibitor. A rapid and sensitive liquid chromatography tandem mass spectrometry method was developed and validated for the quantification of IKH12 in rat plasma and tissue with kendine 91 as internal standard (IS). The samples were prepared by liquid–liquid extraction with tert‐butyl methyl ether. The chromatographic separation was accomplished by using a Zorbax Extend C18 4.6 × 150 mm, 5 µm column, with a mobile phase consisting of methanol and 0.1% formic acid (75:25 v/v). Multiple reaction monitoring, using electrospray ionization in positive ion mode, was employed to quantitatively detect IKH12 and IS. The monitored transitions were set at m/z 418 → 252 and 444 → 169 for IKH12 and kendine 91, respectively. The calibration curve was linear over the concentration range 2–1000 ng mL−1. The intra‐ and inter‐assay precision and accuracy of the quality controls and the limit of quantification were satisfactory in all cases (according to European Medicines Agency guidelines). Stability studies showed that plasma samples were stable in the chromatography rack for 24 h and at −80 °C for 2 months and also after three freeze–thaw cycles. This method was successfully applied to a pharmacokinetic study of IKH12 in rat. Copyright © 2015 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0269-3879</identifier><identifier>EISSN: 1099-0801</identifier><identifier>DOI: 10.1002/bmc.3414</identifier><identifier>PMID: 25616154</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>analytical validation ; Animals ; Antineoplastic Agents - blood ; Chromatography, High Pressure Liquid - methods ; histone deacetylase inhibitor ; Histone Deacetylase Inhibitors - blood ; Hydroxamic Acids - blood ; IKH12 ; Limit of Detection ; liquid chromatography ; Liquid-Liquid Extraction - methods ; Male ; mass spectrometry ; Methyl Ethers - chemistry ; pharmacokinetics ; Proline - analogs &amp; derivatives ; Proline - blood ; Rats, Wistar ; selective inhibitor ; Spectrometry, Mass, Electrospray Ionization - methods ; Tandem Mass Spectrometry - methods</subject><ispartof>Biomedical chromatography, 2015-08, Vol.29 (8), p.1249-1258</ispartof><rights>Copyright © 2015 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4934-3a0a9e96a489160a6c454b33db0c00e02c1d35593451251131096cafc4a8ade53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25616154$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Otaegui, Dorleta</creatorcontrib><creatorcontrib>Masdeu, Carme</creatorcontrib><creatorcontrib>Aldaba, Eneko</creatorcontrib><creatorcontrib>Vara, Yosu</creatorcontrib><creatorcontrib>Zubia, Aizpea</creatorcontrib><creatorcontrib>San Sebastian, Eider</creatorcontrib><creatorcontrib>Alcalá, Maria</creatorcontrib><creatorcontrib>Villafruela, Sergio</creatorcontrib><creatorcontrib>Cossío, Fernando P.</creatorcontrib><creatorcontrib>Rodriguez-Gascón, Alicia</creatorcontrib><title>Development and validation of a LC-MS assay for the quantification of ikh12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study</title><title>Biomedical chromatography</title><addtitle>Biomed. Chromatogr</addtitle><description>IKH12 is a novel histone deacetylase 6 selective inhibitor. A rapid and sensitive liquid chromatography tandem mass spectrometry method was developed and validated for the quantification of IKH12 in rat plasma and tissue with kendine 91 as internal standard (IS). The samples were prepared by liquid–liquid extraction with tert‐butyl methyl ether. The chromatographic separation was accomplished by using a Zorbax Extend C18 4.6 × 150 mm, 5 µm column, with a mobile phase consisting of methanol and 0.1% formic acid (75:25 v/v). Multiple reaction monitoring, using electrospray ionization in positive ion mode, was employed to quantitatively detect IKH12 and IS. The monitored transitions were set at m/z 418 → 252 and 444 → 169 for IKH12 and kendine 91, respectively. The calibration curve was linear over the concentration range 2–1000 ng mL−1. The intra‐ and inter‐assay precision and accuracy of the quality controls and the limit of quantification were satisfactory in all cases (according to European Medicines Agency guidelines). Stability studies showed that plasma samples were stable in the chromatography rack for 24 h and at −80 °C for 2 months and also after three freeze–thaw cycles. This method was successfully applied to a pharmacokinetic study of IKH12 in rat. Copyright © 2015 John Wiley &amp; Sons, Ltd.</description><subject>analytical validation</subject><subject>Animals</subject><subject>Antineoplastic Agents - blood</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>histone deacetylase inhibitor</subject><subject>Histone Deacetylase Inhibitors - blood</subject><subject>Hydroxamic Acids - blood</subject><subject>IKH12</subject><subject>Limit of Detection</subject><subject>liquid chromatography</subject><subject>Liquid-Liquid Extraction - methods</subject><subject>Male</subject><subject>mass spectrometry</subject><subject>Methyl Ethers - chemistry</subject><subject>pharmacokinetics</subject><subject>Proline - analogs &amp; derivatives</subject><subject>Proline - blood</subject><subject>Rats, Wistar</subject><subject>selective inhibitor</subject><subject>Spectrometry, Mass, Electrospray Ionization - methods</subject><subject>Tandem Mass Spectrometry - methods</subject><issn>0269-3879</issn><issn>1099-0801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqF0ctu1DAUBmALgehQkHgC5CWblOP4kngJAQrVFIQol511xnE0ZnJr7LSdx-IN8bTTYYVYHUv-9Ns6PyHPGZwwgPzVqrMnXDDxgCwYaJ1BCewhWUCudMbLQh-RJyH8AgCt8uIxOcqlYopJsSC_37or1w5j5_pIsa_pFba-xuiHng4NRbqssvOvFEPALW2Gica1o5cz9tE33h6c36xZnnQ_pDS6u83i3CVuU-Yuz1Hf0wkjHVsMHd4-FX0Iswu3Zx_THMf2PjNppOMapw7tsPG9i97SEOd6-5Q8arAN7tl-HpNv799dVB-y5efTj9XrZWaF5iLjCKidVihKzRSgskKKFef1CiyAg9yymkuZqGS5ZIynxSmLjRVYYu0kPyYv73LHabhM34ym88G6tsXeDXMwrAAm0m7L4v9U6SJnTAD8pXYaQphcY8bJdzhtDQOz69KkLs2uy0Rf7FPnVefqA7wvL4HsDlz71m3_GWTenFf7wL33Ibqbg8dpY1TBC2l-fDo1P7-cLb_r6sxc8D8l27go</recordid><startdate>201508</startdate><enddate>201508</enddate><creator>Otaegui, Dorleta</creator><creator>Masdeu, Carme</creator><creator>Aldaba, Eneko</creator><creator>Vara, Yosu</creator><creator>Zubia, Aizpea</creator><creator>San Sebastian, Eider</creator><creator>Alcalá, Maria</creator><creator>Villafruela, Sergio</creator><creator>Cossío, Fernando P.</creator><creator>Rodriguez-Gascón, Alicia</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>201508</creationdate><title>Development and validation of a LC-MS assay for the quantification of ikh12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study</title><author>Otaegui, Dorleta ; Masdeu, Carme ; Aldaba, Eneko ; Vara, Yosu ; Zubia, Aizpea ; San Sebastian, Eider ; Alcalá, Maria ; Villafruela, Sergio ; Cossío, Fernando P. ; Rodriguez-Gascón, Alicia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4934-3a0a9e96a489160a6c454b33db0c00e02c1d35593451251131096cafc4a8ade53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>analytical validation</topic><topic>Animals</topic><topic>Antineoplastic Agents - blood</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>histone deacetylase inhibitor</topic><topic>Histone Deacetylase Inhibitors - blood</topic><topic>Hydroxamic Acids - blood</topic><topic>IKH12</topic><topic>Limit of Detection</topic><topic>liquid chromatography</topic><topic>Liquid-Liquid Extraction - methods</topic><topic>Male</topic><topic>mass spectrometry</topic><topic>Methyl Ethers - chemistry</topic><topic>pharmacokinetics</topic><topic>Proline - analogs &amp; derivatives</topic><topic>Proline - blood</topic><topic>Rats, Wistar</topic><topic>selective inhibitor</topic><topic>Spectrometry, Mass, Electrospray Ionization - methods</topic><topic>Tandem Mass Spectrometry - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Otaegui, Dorleta</creatorcontrib><creatorcontrib>Masdeu, Carme</creatorcontrib><creatorcontrib>Aldaba, Eneko</creatorcontrib><creatorcontrib>Vara, Yosu</creatorcontrib><creatorcontrib>Zubia, Aizpea</creatorcontrib><creatorcontrib>San Sebastian, Eider</creatorcontrib><creatorcontrib>Alcalá, Maria</creatorcontrib><creatorcontrib>Villafruela, Sergio</creatorcontrib><creatorcontrib>Cossío, Fernando P.</creatorcontrib><creatorcontrib>Rodriguez-Gascón, Alicia</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Biomedical chromatography</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Otaegui, Dorleta</au><au>Masdeu, Carme</au><au>Aldaba, Eneko</au><au>Vara, Yosu</au><au>Zubia, Aizpea</au><au>San Sebastian, Eider</au><au>Alcalá, Maria</au><au>Villafruela, Sergio</au><au>Cossío, Fernando P.</au><au>Rodriguez-Gascón, Alicia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and validation of a LC-MS assay for the quantification of ikh12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study</atitle><jtitle>Biomedical chromatography</jtitle><addtitle>Biomed. Chromatogr</addtitle><date>2015-08</date><risdate>2015</risdate><volume>29</volume><issue>8</issue><spage>1249</spage><epage>1258</epage><pages>1249-1258</pages><issn>0269-3879</issn><eissn>1099-0801</eissn><abstract>IKH12 is a novel histone deacetylase 6 selective inhibitor. A rapid and sensitive liquid chromatography tandem mass spectrometry method was developed and validated for the quantification of IKH12 in rat plasma and tissue with kendine 91 as internal standard (IS). The samples were prepared by liquid–liquid extraction with tert‐butyl methyl ether. The chromatographic separation was accomplished by using a Zorbax Extend C18 4.6 × 150 mm, 5 µm column, with a mobile phase consisting of methanol and 0.1% formic acid (75:25 v/v). Multiple reaction monitoring, using electrospray ionization in positive ion mode, was employed to quantitatively detect IKH12 and IS. The monitored transitions were set at m/z 418 → 252 and 444 → 169 for IKH12 and kendine 91, respectively. The calibration curve was linear over the concentration range 2–1000 ng mL−1. The intra‐ and inter‐assay precision and accuracy of the quality controls and the limit of quantification were satisfactory in all cases (according to European Medicines Agency guidelines). Stability studies showed that plasma samples were stable in the chromatography rack for 24 h and at −80 °C for 2 months and also after three freeze–thaw cycles. This method was successfully applied to a pharmacokinetic study of IKH12 in rat. Copyright © 2015 John Wiley &amp; Sons, Ltd.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>25616154</pmid><doi>10.1002/bmc.3414</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0269-3879
ispartof Biomedical chromatography, 2015-08, Vol.29 (8), p.1249-1258
issn 0269-3879
1099-0801
language eng
recordid cdi_proquest_miscellaneous_1701487987
source Wiley-Blackwell Read & Publish Collection
subjects analytical validation
Animals
Antineoplastic Agents - blood
Chromatography, High Pressure Liquid - methods
histone deacetylase inhibitor
Histone Deacetylase Inhibitors - blood
Hydroxamic Acids - blood
IKH12
Limit of Detection
liquid chromatography
Liquid-Liquid Extraction - methods
Male
mass spectrometry
Methyl Ethers - chemistry
pharmacokinetics
Proline - analogs & derivatives
Proline - blood
Rats, Wistar
selective inhibitor
Spectrometry, Mass, Electrospray Ionization - methods
Tandem Mass Spectrometry - methods
title Development and validation of a LC-MS assay for the quantification of ikh12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T17%3A15%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20validation%20of%20a%20LC-MS%20assay%20for%20the%20quantification%20of%20ikh12%20a%20novel%20anti-tumor%20candidate%20in%20rat%20plasma%20and%20tissues%20and%20its%20application%20in%20a%20pharmacokinetic%20study&rft.jtitle=Biomedical%20chromatography&rft.au=Otaegui,%20Dorleta&rft.date=2015-08&rft.volume=29&rft.issue=8&rft.spage=1249&rft.epage=1258&rft.pages=1249-1258&rft.issn=0269-3879&rft.eissn=1099-0801&rft_id=info:doi/10.1002/bmc.3414&rft_dat=%3Cproquest_cross%3E1697211400%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4934-3a0a9e96a489160a6c454b33db0c00e02c1d35593451251131096cafc4a8ade53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1697211400&rft_id=info:pmid/25616154&rfr_iscdi=true